Making dendritic cells from the inside out: Lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro

Human Gene Therapy

Volumn 15, Issue 8, 2004, Pages 733-748

  Koya, Richard C ^a   Weber, Jeffrey S ^b   Kasahara, Nori ^a   Lau, Roy ^b   Villacres, Maria C ^c   Levine, Alexandra M ^b   Stripecke, Renata ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T6 ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA MODIFICATION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANALYSIS OF VARIANCE; ANTIGENS, CD14; CELL DIFFERENTIATION; CLONING, MOLECULAR; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LENTIVIRUS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

LENTIVIRUS;

EID: 4143102356     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/1043034041648381     Document Type: Article

References (34)

1. BANCHEREAU, J., and STEINMAN, R.M. (1998). Dendritic cell s and the control of immunity. Nature 392, 245-252.
2. - human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 96, 2988-2993.
3. CAVANAGH, L.L., SAAL, R.J., GRIMMETT, K.L., and THOMAS, R. (1998). Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation. Blood 92, 1598-1607.
4. CURIEL-LEWANDROWSKI, C., MAHNKE, K., LABEUR, M., ROTERS, B., SCHMIDT, W., GRANSTEIN, R.D., LUGER, T.A., SCHWARZ, T., and GRABBE, S. (1999). Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity. J. Immunol. 163, 174-183.
5. - dendritic cell precursors. J. Immunol. 166, 848-854.
6. DULL, T., ZUFFEREY, R., KELLY, M., MANDEL, R.J., NGUYEN, M., TRONO, D., and NALDINI, L. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
7. DYALL, J., LATOUCHE, J.B., SCHNELL, S., and SADELAIN, M. (2001). Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97, 114-121.
8. EGGERT, A.A., SCHREURS, M.W., BOERMAN, O.C., OYEN, W.J., DE BOER, A.J., PUNT, C.J., FIGDOR, C.G., and ADEMA, G.J. (1999). Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59, 3340-3345.
9. FADERL, S., HARRIS, D., VAN, Q., KANTARJIAN, H.M., TALPAZ, M., and ESTROV, Z. (2003). Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 102, 630-637.
10. GRUBER, A., KAN-MITCHELL, J., KUHEN, K.L., MUKAI, T., and WONG-STAAL, F. (2000). Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96, 1327-1333.
11. HEIDENREICH, S. (1999). Monocyte CD14: A multifunctional receptor engaged in apoptosis from both sides. J. Leukoc. Biol. 65, 737-743.
12. HUBERT, P., GREIMERS, R., FRANZEN-DETROOZ, E., DOYEN, J., DELANAYE, P., BONIVER, J., and DELVENNE, P. (1998). In vitro propagated dendritic cells from patients with human-papilloma virus-associated preneoplastic lesions of the uterine cervix: Use of Flt3 ligand. Cancer Immunol. Immunother. 47, 81-89.
13. INABA, K., STEINMAN, R.M., PACK, M.W., AYA, H., INABA, M., SUDO, T., WOLPE, S., and SCHULER, G. (1992). Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 175, 1157-1167.
14. KLEIN, C., BUELER, H., and MULLIGAN, R.C. (2000). Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J. Exp. Med. 191, 1699-1708.
15. KOYA, R.C., KASAHARA, N., PULLARKAT, V., LEVINE, A.M., and STRIPECKE, R. (2002). Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: Effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses. Leukemia 16, 1645-1654.
16. KOYA, R.C., KASAHARA, N., FAVARO, P.M., LAU, R., TA, H.Q., WEBER, J.S., and STRIPECKE, R. (2003). Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery. J. Immunother. 26, 451-460.
17. LUTZ, M.B., SURI, R.M., NIIMI, M., OGILVIE, A.L., KUKUTSCH, N.A., ROSSNER, S., SCHULER, G., and AUSTYN, J.M. (2000). Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Tmmunol. 30, 1813-1822.
18. MARASKOVSKY, E., BRASEL, K., TEEPE, M., ROUX, E.R., LYMAN, S.D., SHORTMAN, K., and MCKENNA, H.J. (1996). Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962.
19. MORSE, M.A., COLEMAN, R.E., AKABANI, G., NIEHAUS, N., COLEMAN, D., and LYERLY, H.K. (1999). Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59, 56-58.
20. PREISLER, H.D., LI, B., YANG, B.L., HUANG, R.W., DEVEMY, E., VENUGOPAL, P., TAO, M., CHOPRA, H., GREGORY, S.A., ADLER, S., SIVARAMAN, S., TOOFANFARD, P., JAJEH, A., GALVEZ, A., and ROBIN, E. (2000). Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4. Clin. Cancer Res. 6, 807-812.
21. RIBAS, A., BUTTERFIELD, L.H., GLASPY, J.A., and ECONOMOU, J.S. (2003). Current developments in cancer vaccines and cellular immunotherapy. J. Clin. Oncol. 21, 2415-2432.
22. ROMANI, N., GRUNER, S., BRANG, D., KAMPGEN, E., LENZ, A., TROCKENBACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M., and SCHULER, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
23. ROSSI, H.A., O'DONNELL, J., SARCINELLI, F., STEWART, P.M., QUESENBERRY, P.J., and BECKER, P.S. (2002). Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia 16, 310-315.
24. RUEDL, C., KOEBEL, P., BACHMANN, M., HESS, M., and KARJALAINEN, K. (2000). Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165, 4910-4916.
25. SALLUSTO, F., and LANZAVECCHIA, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
26. SCHROERS, R., SINHA, I., SEGALL, H., SCHMIDT-WOLF, I.G., ROONEY, C.M., BRENNER, M.K., SUTTON, R.E., and CHEN, S.Y. (2000). Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther. 1, 171-179.
27. SCHULER, G., and STEINMAN, R.M. (1997). Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183-1187.
28. + blood progenitors for anti-cancer therapy. Exp. Hematol. 23, 1463-1471.
29. STOCKING, C., KAWAI, M., LAKER, C., LOLIGER, C., KLUGE, N., KLINGLER, K., and OSTERTAG, W. (1989). Conversion of factor-dependent myeloid cells to factor independence: Autocrine stimulation is not coincident with tumorigenicity. Curr. Top. Microbiol. Immunol. 149, 117-126.
30. STRIPECKE, R., CARDOSO, A.A., PEPPER, K.A., SKELTON, D.C., YU, X.J., MASCARENHAS, L., WEINBERG, K.I., NADLER, L.M., and KOHN, D.B. (2000). Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood 96, 1317-1326.
31. STRIPECKE, R., KOYA, R.C., TA, H.Q., KASAHARA, N., and LEVINE, A.M. (2003). The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol. Dis. 31, 28-37.
32. VISSER, M., SONNEVELD, R.D., WILLEMZE, R., and LANDECENT, J.E. (1996). Haemopoietic growth factor tyrosine kinase receptor expression profiles in normal haemopoiesis. Br. J. Haematol. 94, 236-241.
33. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.
34. ZUFFEREY, R., DONELLO, J.E., TRONO, D., and HOPE, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892.